New cancer clinical trial: Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor

Published on: September 12, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share